UBS Group AG - CYCLACEL PHARMACEUTICALS INC ownership

CYCLACEL PHARMACEUTICALS INC's ticker is CYCCP and the CUSIP is 23254L207. A total of 2 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CYCLACEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$66
-79.4%
6
-73.9%
0.00%
Q1 2023$321
-92.0%
23
-95.8%
0.00%
Q3 2022$4,0000.0%548
+8.9%
0.00%
Q2 2022$4,0000.0%503
-20.0%
0.00%
Q1 2022$4,0000.0%629
-7.1%
0.00%
Q4 2021$4,000
-82.6%
677
-82.6%
0.00%
Q1 2020$23,000
+15.0%
3,891
-4.3%
0.00%
Q4 2019$20,0000.0%4,067
-8.2%
0.00%
Q3 2019$20,000
+81.8%
4,428
+98.7%
0.00%
Q2 2019$11,0000.0%2,228
-7.7%
0.00%
Q1 2019$11,000
-8.3%
2,415
+4.3%
0.00%
Q4 2018$12,000
+9.1%
2,315
+7.0%
0.00%
Q3 2018$11,000
-26.7%
2,1640.0%0.00%
Q2 2018$15,000
+15.4%
2,164
+0.0%
0.00%
Q1 2018$13,000
+225.0%
2,163
+279.5%
0.00%
Q4 2017$4,000
+100.0%
570
+111.1%
0.00%
Q3 2017$2,000
-50.0%
270
-55.7%
0.00%
Q1 2017$4,000
-66.7%
609
-69.0%
0.00%
Q4 2016$12,000
+140.0%
1,965
+186.4%
0.00%
Q3 2016$5,000
-44.4%
686
-52.8%
0.00%
Q2 2016$9,000
+200.0%
1,454
+144.8%
0.00%
Q1 2016$3,000
+200.0%
594
+266.7%
0.00%
Q4 2015$1,0000.0%162
-0.6%
0.00%
Q3 2015$1,0000.0%1630.0%0.00%
Q2 2015$1,0000.0%163
-1.2%
0.00%
Q1 2015$1,0000.0%165
-4.1%
0.00%
Q4 2014$1,0001720.00%
Other shareholders
CYCLACEL PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CYCLACEL PHARMACEUTICALS INC shareholders